http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020079217-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad2cd796f8c4dcb425ddcc68707d3444 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12 |
| filingDate | 2018-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36ca1587db8960cc78158c8d7715c744 |
| publicationDate | 2020-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2020079217-A |
| titleOfInvention | Method for producing cataract prevention agent |
| abstract | An object of the present invention is to provide an agent capable of suppressing abnormal aggregation and/or insolubilization of crystallin, which is a constituent protein of the lens. The present invention provides [a] a step of adhering mesenchymal stem cells to the inner surface of a hollow fiber membrane, [b] perfusing a cell culture solution into the inner and outer cavities of the hollow fiber membrane, and A method for producing a preventive or therapeutic agent for cataract, which comprises the step of culturing mesenchymal stem cells, and [c] collecting the culture supernatant obtained by culturing the mesenchymal stem cells. [Selection diagram] None |
| priorityDate | 2018-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.